The clinical significance of GBV-C/HGV exposure in C-viral chronic liver disease and blood donors

Hepatology Research

Volumn 22, Issue 4, 2002, Pages 288-296

  Saitoh, Hiroshi ^a   Moriyama, Mitsuhiko ^a   Matsumura, Hiroshi ^a   Goto, Iori ^a   Tanaka, Naohide ^a   Aarakawa, Yasuyuki ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis C; Hepatitis C virus RNA; Hepatitis G virus E2 antibody; Hepatitis G virus RNA; Hepatocellular carcinoma; Liver cirrhosis

Indexed keywords

HEPATITIS ANTIBODY; INTERFERON; VIRUS RNA;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; HEMATOLOGICAL PARAMETERS; HEPATITIS C; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0036256866     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(01)00152-8     Document Type: Article

References (32)

1. Isolation of novel virus-like sequences associated with human hepatitis
2. Molecular cloning and disease association of hepatitis G. virus: A transfusion-transmissible agent
3. Sequence and genomic organization of GBV-C: A novel member of the Flaviridae associated with human non A-E hepatitis
4. The cloning and clinical implications of HGV and GBV-C
5. Infection with hepatitis GB virus C in patients on maintenance hemodialysis
6. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease
7. Biochemical and virological response to interferon therapy in patients with chronic hepatitis C coinfected with hepatitis G virus
8. Detection of antibodies to a putative hepatitis G virus envelope protein
9. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker
10. Analysis of hepatitis G virus (HGV) RNA, Antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus
11. Significance of antibodies to the recombinant E2 protein of hepatitis G virus in haemodialysis patients
12. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis
13. An ELISA for detection of antibodies to the E2 protein of GB virus C
14. Seroprevalence of GB virus C and persistence of RNA and antibody
15. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): Is it a marker for immunity
16. Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations
17. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alpha
18. Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody
19. Classification of chronic hepatitis: Diagnosis, grading and staging
20. The serum hepatitis C virus RNA at two weeks after the administration of interferon: Its predictability for the efficacy of interferon treatment for chronic hepatitis C
21. Prevalence of hepatitis G virus infection among patients with liver diseases in Japan
22. Typing of hepatitis C virus by PCR with type-specific primers: Application to clinical surveys and tracing infectious sources
23. A proposed system for the nomenclature of hepatitis C Viral, genotypes
24. Natural history of liver fibrosis progression in patients with chronic hepatitis C
25. Natural course of progression of liver fibrosis in patients with chronic liver disease type C in Japan - A study of 527 patients at one establishment in Japan
26. Histopathologic impact of GB virus C infection on chronic hepatitis C
27. Comparative histologic features of liver biopsy specimens from patients coinfected with hepatitis G and C viruses with chronic hepatitis C virus alone. An age-, sex-, disease duration-, and transmission-matched chronic hepatitis
28. Hepatic histology in hepatitis C virus carriers coinfected with hepatitis G virus
29. Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology
30. Hepatitis G virus coinfection influences the liver histology of patients with chronic hepatitis C
31. An ELISA for detection of antibodies to the E2 protein of GB virus C
32. Distinct prevalence of antibodies to the E2 protein of GB virus C/hepatitis G virus in different parts of the world